Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 3 1Phase 1/2 1

Status

Completed 19Unknown 15Recruiting 7Not yet recruiting 6Terminated 3Active not recruiting 1

Sponsor Class

OTHER 16INDUSTRY 7OTHER_GOV 2

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Breast 7Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 429Breast Neoplasms 298Neoplasms 296Colorectal Neoplasms 242Neoplasm Metastasis 197Ovarian Neoplasms 171Lung Neoplasms 150Recurrence 147Prostatic Neoplasms 146Pancreatic Neoplasms 142Multiple Myeloma 136Stomach Neoplasms 129Squamous Cell Carcinoma of Head and Neck 128Melanoma 123Leukemia, Myeloid, Acute 115Endometrial Neoplasms 115Advanced Solid Tumors 113Advanced Solid Tumor 108Carcinoma, Hepatocellular 102Triple Negative Breast Neoplasms 101Small Cell Lung Carcinoma 88Uterine Cervical Neoplasms 86Lymphoma, Non-Hodgkin 83Carcinoma, Renal Cell 72Lymphoma, Follicular 71Lymphoma 67Leukemia, Lymphocytic, Chronic, B-Cell 65Solid Tumor 64Lymphoma, Large B-Cell, Diffuse 64Hematologic Neoplasms 62

Interventions

AZD9833 2ribociclib 1palbociclib 1exemestane 1elacestrant 1abemaciclib 1Vinorelbine 1Letrozole 1Injections 1Fulvestrant 1Anastrozole 1AZD5305 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Advanced Breast Cancer × Clear all
NCT07427394 2026-05-28

SERENA-1b

AstraZeneca

Phase 2 Recruiting
24 enrolled
Breast

Advanced Breast Cancer

NCT06380751 2026-05-15

EvoPAR-BR01

AstraZeneca

Phase 3 Recruiting
500 enrolled
Breast

Advanced Breast Cancer

NCT06638307 2026-05-12

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

Stemline Therapeutics, Inc.

Phase 1 Recruiting
240 enrolled
Breast

Advanced Breast Cancer

NCT07130383 2025-11-18

A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors

Minghui Pharmaceutical (Hangzhou) Ltd

Phase 2 Recruiting
210 enrolled
BreastOther solid neoplasm

Advanced Breast Cancer

NCT07101601 2025-08-03

Study of DM5167 in Patients With Advanced Solid Tumors

DIGMBIO

Phase 1 Recruiting
58 enrolled
Breast

Advanced Breast Cancer

NCT06500494 2025-07-24

VINOREAL

Pierre Fabre Medicament

Recruiting
368 enrolled
Breast

Advanced Breast Cancer

NCT03474822 2024-02-20

Plasmodium Immunotherapy for Breast and Liver Cancers

CAS Lamvac Biotech Co., Ltd.

Phase 1/2 Recruiting
60 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡